How Will the Market React to Biohaven Ltd (BHVN) Stock Getting a Bearish Rating

Overall market sentiment has been down on Biohaven Ltd (BHVN) stock lately. BHVN receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Biohaven Ltd has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on BHVN!

See Full BHVN Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With BHVN Stock Today?

Biohaven Ltd (BHVN) stock is trading at $28.38 as of 12:13 PM on Monday, Nov 13, a loss of -$0.21, or -0.73% from the previous closing price of $28.59. The stock has traded between $26.93 and $28.54 so far today. Volume today is less active than usual. So far 178,709 shares have traded compared to average volume of 1,265,665 shares. To screen for more stocks like Biohaven Ltd click here.

More About Biohaven Ltd

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Click Here to get the full Stock Report for Biohaven Ltd stock.